Company
Coulter Corporation
Use
Treatment of patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
Features
The first radioimmunotherapy treatment approved for cancer
NIH Contribution
Method of delivering radioactive compound to the target site while minimizing distribution of the compounds to other organs or tissues
Inventor(s)
O. Gansow and M. Brechiel